We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.31%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$3.83B
AUM Growth
+$365M
Cap. Flow
+$14.3M
Cap. Flow %
0.37%
Top 10 Hldgs %
46.82%
Holding
177
New
6
Increased
30
Reduced
82
Closed
1

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.9M
2
MSFT icon
Microsoft
MSFT
+$14.2M
3
WMS icon
Advanced Drainage Systems
WMS
+$7.62M
4
MA icon
Mastercard
MA
+$3.36M
5
MDXG icon
MiMedx Group
MDXG
+$3.01M

Sector Composition

Rank Sector Weight
1 Financials 38.94%
2 Technology 13.69%
3 Healthcare 13.2%
4 Communication Services 7.56%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$279M 7.3%
820,368
-45,305
-5% -$14.2M
APO icon
2
Apollo Global Management
APO
$69B
$239M 6.24%
3,110,496
+3,692
+0.1% +$247K
BX icon
3
Blackstone
BX
$104B
$221M 5.78%
2,378,951
+1,542
+0.1% +$133K
ESGR
4
DELISTED
Enstar Group
ESGR
$167M 4.36%
682,954
-1,323
-0.2% -$327K
CACC icon
5
Credit Acceptance
CACC
$5.82B
$165M 4.32%
325,353
+980
+0.3% +$459K
AJG icon
6
Arthur J. Gallagher & Co
AJG
$69.1B
$153M 3.99%
694,735
+1,720
+0.2% +$358K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.11T
$143M 3.73%
1,180,504
-11,615
-1% -$1.34M
LH icon
8
Labcorp
LH
$25.2B
$137M 3.57%
658,782
+93,254
+16% +$18.1M
RDNT icon
9
RadNet
RDNT
$4.98B
$106M 2.78%
3,260,242
+7,229
+0.2% +$210K
SCHW
10
Charles Schwab
SCHW
$182B
$105M 2.73%
1,846,249
+192,991
+12% +$10.1M
ROP icon
11
Roper Technologies
ROP
$40.4B
$101M 2.64%
209,983
-1,914
-0.9% -$867K
ABT icon
12
Abbott
ABT
$188B
$85.2M 2.23%
781,689
+4,521
+0.6% +$482K
ZWS icon
13
Zurn Elkay Water Solutions
ZWS
$8.6B
$80M 2.09%
2,974,708
+437,548
+17% +$9.96M
EPD icon
14
Enterprise Products Partners
EPD
$83.7B
$71M 1.86%
2,695,862
+48,318
+2% +$1.26M
CSGP icon
15
CoStar Group
CSGP
$12.2B
$69.8M 1.82%
784,611
+3,104
+0.4% +$240K
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$4.12T
$65.5M 1.71%
547,385
+1,207
+0.2% +$139K
JPM icon
17
JPMorgan Chase
JPM
$916B
$64.6M 1.69%
443,862
-5,683
-1% -$782K
WAT icon
18
Waters Corp
WAT
$37.3B
$64.3M 1.68%
241,301
+13,570
+6% +$3.78M
SHW icon
19
Sherwin-Williams
SHW
$84.8B
$64.3M 1.68%
242,094
-5,769
-2% -$1.36M
JEF icon
20
Jefferies Financial Group
JEF
$12.7B
$61.3M 1.6%
1,847,368
-53,635
-3% -$1.67M
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$61.2M 1.6%
179,563
-2,085
-1% -$680K
FISV
22
Fiserv Inc
FISV
$29.7B
$60.9M 1.59%
482,819
-295
-0.1% -$34.7K
AXP icon
23
American Express
AXP
$224B
$57.1M 1.49%
328,069
+18,622
+6% +$3M
MTDR icon
24
Matador Resources
MTDR
$6.04B
$54.3M 1.42%
1,038,790
+5,145
+0.5% +$249K
HLT icon
25
Hilton Worldwide
HLT
$72.4B
$52.5M 1.37%
360,677
+6,845
+2% +$975K

Similar funds

Beck Mack & Oliver's Q2 2023 Portfolio in Review

As of Q2 2023, Beck Mack & Oliver held 177 positions worth $3.83B, up 11% from $3.46B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4%. Beck Mack & Oliver opened 6 new positions and exited 1, leaving the 177-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Technology and Healthcare.

  • Beck Mack & Oliver's largest Q2 2023 buy was Rush Enterprises Class A: 545,486 shares worth $22.1M.
  • Beck Mack & Oliver added most to Labcorp in Q2 2023, an estimated $18.1M increase.
  • Beck Mack & Oliver's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $15.9M.
  • Beck Mack & Oliver fully exited CAE Inc. Common Shares in Q2 2023, selling an estimated $224K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $3.83B portfolio in Q2 2023.
  • Beck Mack & Oliver opened 6 new positions and closed 1 in Q2 2023.
  • Beck Mack & Oliver's portfolio value rose 11% quarter-over-quarter to $3.83B.

Based on Beck Mack & Oliver's 13F filing for Q2 2023, filed 8 Aug 2023.